Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
175M
-
Number of holders
-
364
-
Total 13F shares, excl. options
-
127M
-
Shares change
-
+695K
-
Total reported value, excl. options
-
$1.15B
-
Value change
-
+$5.54M
-
Put/Call ratio
-
1.25
-
Number of buys
-
157
-
Number of sells
-
-151
-
Price
-
$9.09
Significant Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q4 2024
457 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock as of Q4 2024.
Teladoc Health, Inc. - Common Stock (TDOC) has 364 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 127M shares
of 175M outstanding shares and own 72.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18.5M shares), BlackRock, Inc. (17.1M shares), Point72 Asset Management, L.P. (11.2M shares), GOLDMAN SACHS GROUP INC (6.6M shares), RENAISSANCE TECHNOLOGIES LLC (5.67M shares), STATE STREET CORP (5.08M shares), GEODE CAPITAL MANAGEMENT, LLC (3.95M shares), Maple Rock Capital Partners Inc. (3.56M shares), DIMENSIONAL FUND ADVISORS LP (3.53M shares), and WELLINGTON MANAGEMENT GROUP LLP (3.14M shares).
This table shows the top 364 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.